Literature DB >> 28130334

Blockade of CaMKII depresses conduction preferentially in the right ventricular outflow tract and promotes ischemic ventricular fibrillation in the rabbit heart.

Mark Warren1, Katie J Sciuto2, Tyson G Taylor2, Vivek Garg2, Natalia S Torres2, Junko Shibayama2, Kenneth W Spitzer2, Alexey V Zaitsev2.   

Abstract

Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates the principle ion channels mediating cardiac excitability and conduction, but how this regulation translates to the normal and ischemic heart remains unknown. Diverging results on CaMKII regulation of Na+ channels further prevent predicting how CaMKII activity regulates excitability and conduction in the intact heart. To address this deficiency, we tested the effects of the CaMKII blocker KN93 (1 and 2.75 μM) and its inactive analog KN92 (2.75 μM) on conduction and excitability in the left (LV) and right (RV) ventricles of rabbit hearts during normal perfusion and global ischemia. We used optical mapping to determine local conduction delays and the optical action potential (OAP) upstroke velocity (dV/dtmax). At baseline, local conduction delays were similar between RV and LV, whereas the OAP dV/dtmax was lower in RV than in LV. At 2.75 μM, KN93 heterogeneously slowed conduction and reduced dV/dtmax, with the largest effect in the RV outflow tract (RVOT). This effect was further exacerbated by ischemia, leading to recurrent conduction block in the RVOT and early ventricular fibrillation (at 6.7 ± 0.9 vs. 18.2 ± 0.8 min of ischemia in control, P < 0.0001). Neither KN92 nor 1 μM KN93 depressed OAP dV/dtmax or conduction. Rabbit cardiomyocytes isolated from RVOT exhibited a significantly lower dV/dtmax than those isolated from the LV. KN93 (2.75 μM) significantly reduced dV/dtmax in cells from both locations. This led to frequency-dependent intermittent activation failure occurring predominantly in RVOT cells. Thus CaMKII blockade exacerbates intrinsically lower excitability in the RVOT, which is proarrhythmic during ischemia.NEW &amp; NOTEWORTHY We show that calcium/calmodulin-dependent protein kinase II (CaMKII) blockade exacerbates intrinsically lower excitability in the right ventricular outflow tract, which causes highly nonuniform chamber-specific slowing of conduction and facilitates ventricular fibrillation during ischemia. Constitutive CaMKII activity is necessary for uniform and safe ventricular conduction, and CaMKII block is potentially proarrhythmic.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  calcium/calmodulin-dependent protein kinase II; cardiac conduction; ischemia; right ventricular outflow tract; ventricular fibrillation

Mesh:

Substances:

Year:  2017        PMID: 28130334      PMCID: PMC5407168          DOI: 10.1152/ajpheart.00347.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  49 in total

1.  The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart.

Authors:  A I Fahmi; M Patel; E B Stevens; A L Fowden; J E John; K Lee; R Pinnock; K Morgan; A P Jackson; J I Vandenberg
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

2.  High-precision recording of the action potential in isolated cardiomyocytes using the near-infrared fluorescent dye di-4-ANBDQBS.

Authors:  Mark Warren; Kenneth W Spitzer; Bruce W Steadman; Tyler D Rees; Paul Venable; Tyson Taylor; Junko Shibayama; Ping Yan; Joseph P Wuskell; Leslie M Loew; Alexey V Zaitsev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-02       Impact factor: 4.733

3.  KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels.

Authors:  Saman Rezazadeh; Thomas W Claydon; David Fedida
Journal:  J Pharmacol Exp Ther       Date:  2005-12-20       Impact factor: 4.030

4.  KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart.

Authors:  M E Anderson; A P Braun; Y Wu; T Lu; Y Wu; H Schulman; R J Sung
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

5.  Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients.

Authors:  Junjie Zhang; Frédéric Sacher; Kurt Hoffmayer; Thomas O'Hara; Maria Strom; Phillip Cuculich; Jennifer Silva; Daniel Cooper; Mitchell Faddis; Mélèze Hocini; Michel Haïssaguerre; Melvin Scheinman; Yoram Rudy
Journal:  Circulation       Date:  2015-03-25       Impact factor: 29.690

Review 6.  The multifunctional calcium/calmodulin-dependent protein kinase: from form to function.

Authors:  A P Braun; H Schulman
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

7.  Cardiac CaMKIIδ splice variants exhibit target signaling specificity and confer sex-selective arrhythmogenic actions in the ischemic-reperfused heart.

Authors:  James R Bell; Antonia J A Raaijmakers; Claire L Curl; Melissa E Reichelt; Tristan W Harding; Aier Bei; Dominic C H Ng; Jeffrey R Erickson; Martin Vila Petroff; Stephen B Harrap; Lea M D Delbridge
Journal:  Int J Cardiol       Date:  2014-11-26       Impact factor: 4.164

8.  β-Adrenergic stimulation and rapid pacing mutually promote heterogeneous electrical failure and ventricular fibrillation in the globally ischemic heart.

Authors:  Vivek Garg; Tyson Taylor; Mark Warren; Paul Venable; Katie Sciuto; Junko Shibayama; Alexey Zaitsev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-20       Impact factor: 4.733

9.  Reduced Arrhythmia Inducibility With Calcium/Calmodulin-dependent Protein Kinase II Inhibition in Heart Failure Rabbits.

Authors:  Gregory S Hoeker; Mohamed A Hanafy; Robert A Oster; Donald M Bers; Steven M Pogwizd
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

Review 10.  Ca(2+) current facilitation is CaMKII-dependent and has arrhythmogenic consequences.

Authors:  Donald M Bers; Stefano Morotti
Journal:  Front Pharmacol       Date:  2014-06-17       Impact factor: 5.810

View more
  7 in total

1.  Conduction in the right and left ventricle is differentially regulated by protein kinases and phosphatases: implications for arrhythmogenesis.

Authors:  Alexey V Zaitsev; Natalia S Torres; Keiko M Cawley; Amira D Sabry; Junco S Warren; Mark Warren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-15       Impact factor: 4.733

2.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

3.  CaMKII blockade, cardiac conduction, and arrhythmia.

Authors:  Mark Warren; Alexey V Zaitsev
Journal:  Cardiovasc Res       Date:  2017-12-01       Impact factor: 10.787

4.  Guidelines for experimental models of myocardial ischemia and infarction.

Authors:  Merry L Lindsey; Roberto Bolli; John M Canty; Xiao-Jun Du; Nikolaos G Frangogiannis; Stefan Frantz; Robert G Gourdie; Jeffrey W Holmes; Steven P Jones; Robert A Kloner; David J Lefer; Ronglih Liao; Elizabeth Murphy; Peipei Ping; Karin Przyklenk; Fabio A Recchia; Lisa Schwartz Longacre; Crystal M Ripplinger; Jennifer E Van Eyk; Gerd Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-12       Impact factor: 4.733

Review 5.  Regulatory mechanism of calcium/calmodulin-dependent protein kinase II in the occurrence and development of ventricular arrhythmia (Review).

Authors:  Kexin Ma; Guoping Ma; Zijing Guo; Gang Liu; Wenjie Liang
Journal:  Exp Ther Med       Date:  2021-04-20       Impact factor: 2.447

6.  Chronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure.

Authors:  Yixi Liu; Qun Shao; Heng-Jie Cheng; Tiankai Li; Xiaowei Zhang; Michael F Callahan; David Herrington; Dalane Kitzman; David Zhao; Che-Ping Cheng
Journal:  J Pharmacol Exp Ther       Date:  2021-03-15       Impact factor: 4.402

7.  Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis.

Authors:  Thirupura S Shankar; Dinesh K A Ramadurai; Kira Steinhorst; Salah Sommakia; Rachit Badolia; Aspasia Thodou Krokidi; Dallen Calder; Sutip Navankasattusas; Paulina Sander; Oh Sung Kwon; Aishwarya Aravamudhan; Jing Ling; Andreas Dendorfer; Changmin Xie; Ohyun Kwon; Emily H Y Cheng; Kevin J Whitehead; Thomas Gudermann; Russel S Richardson; Frank B Sachse; Johann Schredelseker; Kenneth W Spitzer; Dipayan Chaudhuri; Stavros G Drakos
Journal:  Nat Commun       Date:  2021-07-28       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.